Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Smart insulin systems aim to simplify diabetes management

NCT ID NCT02994277

First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 32 times

Summary

This pilot study tested two computer algorithms designed to automatically control blood sugar levels in people with type 1 diabetes. Five adults who already use an insulin pump and continuous glucose monitor participated. The goal was to see if the systems could keep blood sugar in a safe range without constant manual input.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Closed-loop insulin delivery system (UVa and ITBA/UNLP algorithms)

What this could lead to

If successful, this could lead to a more automated way to manage blood sugar in type 1 diabetes, reducing the need for manual insulin adjustments.

What could go wrong

This is a very small pilot study with only 5 participants, so results may not apply to everyone. The algorithms may not work as well in real-world conditions or for all patients.

Conditions

The condition(s) this trial relates to.

diabetes mellitus type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.